Patterns of care and dropout rates from outpatient mental healthcare in low-, middle- and high-income countries from the World Health Organization's World Mental Health Survey Initiative

Abstract

Background There is a substantial proportion of patients who drop out of treatment before they receive minimally adequate care. They tend to have worse health outcomes than those who complete treatment. Our main goal is to describe the frequency and determinants of dropout from treatment for mental disorders in low-, middle-, and high-income countries. Methods Respondents from 13 low- or middle-income countries (N = 60 224) and 15 in high-income countries (N = 77 303) were screened for mental and substance use disorders. Cross-tabulations were used to examine the distribution of treatment and dropout rates for those who screened positive. The timing of dropout was examined using Kaplan–Meier curves. Predictors of dropout were examined with survival analysis using a logistic link function. Results Dropout rates are high, both in high-income (30%) and low/middle-income (45%) countries. Dropout mostly occurs during the first two visits. It is higher in general medical rather than in specialist settings (nearly 60% v. 20% in lower income settings). It is also higher for mild and moderate than for severe presentations. The lack of financial protection for mental health services is associated with overall increased dropout from care. Conclusions Extending financial protection and coverage for mental disorders may reduce dropout. Efficiency can be improved by managing the milder clinical presentations at the entry point to the mental health system, providing adequate training, support and specialist supervision for non-specialists, and streamlining referral to psychiatrists for more severe cases.

Perceived helpfulness of service sectors used for mental and substance use disorders: Findings from the WHO World Mental Health Surveys

“…Conversely, in the current study, the odds of being helped ‘a lot’ were halved among patients who were seen only in the general medical sector. This finding is consistent with previous reports of lower perceived helpfulness [ 24 , 26 ] and greater likelihood of drop out from care [ 47 ] among patients seen in this treatment profile. This is of concern, given that the general medical only profile was used by more than one-third (35.4%) of patients in the current study (including 32.2% of those with 2 disorders and 27.3% of those with 3 or more disorders), and has been associated elsewhere with lower effective treatment coverage compared to the specialized mental health sector [ 26 , 48 – 53 ].…”

Delivering the Thinking Healthy Programme as a universal group intervention integrated into routine antenatal care: a randomized-controlled pilot study

“…We found relatively low prevalence of perinatal depression in our sample (3.4%) compared to the rate indicated in a recent study in Turkey (19%) [4]. This could indicate that depressed women might not be accessing routine antenatal care and/or attending the online pregnancy schools [33,34]. To increase the reach of the intervention, it would be important to raise community mental health awareness such as through media campaigns or community champions and screening for all women who attend antenatal care.…”

Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice

“…In healthy volunteers, CBD enhances caudate and hippocampal activation and fronto-striatal connectivity during salience processing [ 12 , 13 ] and under resting state conditions [ 16 ], enhances auditory and visual processing [ 19 ] and effects working and episodic memory associated with an increase in blood flow to the hippocampus [ 14 ]. CBD alters functional coupling in cerebellum, frontal, and occipital cortices in patients with treatment resistant epilepsy [ 17 ] and attenuates hippocampal-striatal functional connectivity in psychosis patients [ 18 ]. All these studies gave oral doses of CBD prior to scanning, thus establishing a baseline of resting state blood flow that changed with different task-related paradigms or differed from placebo or healthy controls in response to a preexisting condition.…”